Piper Sandler Maintains Overweight on BXP, Lowers Price Target to $72

Benzinga · 3d ago
Piper Sandler analyst Alexander Goldfarb maintains BXP (NYSE:BXP) with a Overweight and lowers the price target from $88 to $72.